Cited 19 times in
PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 백순명 | - |
dc.contributor.author | 정재호 | - |
dc.date.accessioned | 2022-08-19T06:23:27Z | - |
dc.date.available | 2022-08-19T06:23:27Z | - |
dc.date.issued | 2019-12 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/189124 | - |
dc.description.abstract | Although gastric cancer is a common cause of cancer mortality worldwide, its biological heterogeneity limits the available therapeutic options. Therefore, identifying novel therapeutic targets for developing effective targeted therapy of gastric cancer is a pressing need. Here, we investigate molecular function and regulatory mechanisms of Vestigial-like 1 (VGLL1) in gastric cancer. Microarray analysis of 556 gastric cancer tissues revealed that VGLL1 was a prognostic biomarker that correlated with PI3KCA and PI3KCB. VGLL1 regulates the proliferation of gastric cancer cells, as shown in live cell imaging, sphere formation, and in vivo xenograft model. Tail vein injection of NUGC3 cells expressing shVGLL1 resulted in less lung metastasis occurring when compared to the control. In contrast, larger metastatic lesions in lung and liver were detected in the VGLL1-overexpressing NUGC3 cell xenograft excision mouse model. Importantly, VGLL1 expression is transcriptionally regulated by the PI3K-AKT-beta-catenin pathway. Subsequently, MMP9, a key molecule in gastric cancer, was explored as one of target genes that were transcribed by VGLL1-TEAD4 complex, a component of the transcription factor. Taken together, PI3K/AKT/beta-catenin signaling regulates the transcription of VGLL1, which promotes the proliferation and metastasis in gastric cancer. This finding suggests VGLL1 as a novel prognostic biomarker and a potential therapeutic target. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | CANCERS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | BioMedical Science Institute (의생명과학부) | - |
dc.contributor.googleauthor | Bo-Kyung Kim | - |
dc.contributor.googleauthor | Jae-Ho Cheong | - |
dc.contributor.googleauthor | Joo-Young Im | - |
dc.contributor.googleauthor | Hyun Seung Ban | - |
dc.contributor.googleauthor | Seon-Kyu Kim | - |
dc.contributor.googleauthor | Mi-Jung Kang | - |
dc.contributor.googleauthor | Jungwoon Lee | - |
dc.contributor.googleauthor | Seon-Young Kim | - |
dc.contributor.googleauthor | Kyung-Chan Park | - |
dc.contributor.googleauthor | Soonmyung Paik | - |
dc.contributor.googleauthor | Misun Won | - |
dc.identifier.doi | 10.3390/cancers11121923 | - |
dc.contributor.localId | A01823 | - |
dc.contributor.localId | A03717 | - |
dc.relation.journalcode | J03449 | - |
dc.identifier.eissn | 2072-6694 | - |
dc.identifier.pmid | 31816819 | - |
dc.subject.keyword | gastric cancer | - |
dc.subject.keyword | MMP9 | - |
dc.subject.keyword | PI3K | - |
dc.subject.keyword | VGLL1 | - |
dc.contributor.alternativeName | Paik, Soon Myung | - |
dc.contributor.affiliatedAuthor | 백순명 | - |
dc.contributor.affiliatedAuthor | 정재호 | - |
dc.citation.volume | 11 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1923 | - |
dc.identifier.bibliographicCitation | CANCERS, Vol.11(12) : 1923, 2019-12 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.